Lv71
3850 积分 2024-02-19 加入
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
1个月前
已完结
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
1个月前
已完结
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
1个月前
已完结
RAP1A Suppresses Hepatic Steatosis via Regulating the Amino Acid Mediated mTORC1 Activation
3个月前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
3个月前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
3个月前
已完结
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024）
4个月前
已完结
Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study
5个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
5个月前
已完结
皖公网安备34019202002308
